FIELD: chemistry.
SUBSTANCE: invention relates to a novel α-crystalline form of ethyl ether of 6-bromo-5-hydroxy-4-dimethyl aminomethyl-1-methyl-2-phenylthiomethylindole-3-carboxylic acid hydrochloride monohydrate, which is characterised by the following X-ray diffraction parameters
The invention also relates to a method of producing said compound, involving bromination of ethyl ether of 5-acetoxy-1,2-dimethylindole-3-carboxylic acid to obtain ethyl-5-acetoxy-6-bromo-2-bromomethyl-1-methylindole-3-carboxyl, alkylation thereof with thiophenolate of an alkali metal at temperature 15-60°C for 1-2 hours, to obtain ethyl ether of 6-bromo-5-hydroxy-1-methyl-2-phenylthiomethyl-indole-3-carboxylic acid, aminomethylation thereof with dimethylamine to obtain ethyl ether of 6-bromo-5-hydroxy-4-dimethyl aminomethyl-1-methyl-2-phenylthiomethylindole-3-carboxylic acid with subsequent conversion of the obtained compound to a hydrochloride monohydrate and recrystallisation from ethanol or a mixture of ethanol and acetone.
EFFECT: improved method.
7 cl, 3 dwg, 6 ex
Title | Year | Author | Number |
---|---|---|---|
6-BROMO -5- HYDROXY-4- DIMETHYLAMINOMETHYL -1- METHYL -2-PHENYLTHIO- METHYLINDOLE -3- CARBOXYLIC ACID ETHYL ESTER HYDROCHLORIDE | 1974 |
|
RU2033156C1 |
ARBIDOL-BASE MEDICINAL AGENT | 2003 |
|
RU2240784C1 |
1-METHYL-2-PHENYLTHIOMETHYL-3-CARBETHOXY-4-DIMETHYLAMINOMETHYL-5- HYDROXY-6 -BROMOINDOLE MESYLATE ELICITING ANTIVIRAL ACTIVITY AND PHARMACEUTICAL COMPOSITION WITH ITS USAGE | 2004 |
|
RU2255086C1 |
MEDICINAL AGENT FOR TREATMENT OF ATYPICAL PNEUMONIA | 2004 |
|
RU2256451C1 |
DERIVATIVE 4-AMINOMETHYL-6-BROMINE-5-HYDROXYINDOLE-3-CARBOXYLATE, METHODS OF THEIR OBTAINING (VERSIONS) AND THEIR APPLICATION | 2006 |
|
RU2330018C2 |
5-SUBSTITUTED INDOLE-3-CARBOXYLIC ACID DERIVATIVES, HAVING ANTIVIRAL ACTIVITY, SYNTHESIS METHOD THEREOF AND USE | 2007 |
|
RU2387642C2 |
INDOLE-3-CARBOXYLIC ACID DERIVATIVES HAVING ANTIVIRAL ACTIVITY | 2013 |
|
RU2552422C2 |
PROPHYLACTIC AND CURATIVE AGENT FOR TREATING FLU VIRUS B | 1986 |
|
RU2008004C1 |
PHARMACEUTICAL COMPOSITION EXHIBITING ANTI-INFLAMMATORY, PARTICULARLY ANTIASTHMATIC ACTION, APPLICATIONS OF PHARMACEUTICAL COMPOSITION (VERSIONS) AND DRUG (VERSIONS) | 2008 |
|
RU2406498C2 |
ANTI-INFLAMMATORY AND ANTI-ALLERGIC MEDICATION AND BASED ON IT PHARMACEUTICAL COMPOSITION | 2009 |
|
RU2426540C1 |
Authors
Dates
2012-04-20—Published
2010-08-17—Filed